Literature DB >> 9566421

Cytologically negative carcinomatous meningitis: usefulness of CSF biochemical markers.

M C Chamberlain1.   

Abstract

Eighteen patients (age range, 28 to 62 years; median, 58) with carcinomatous meningitis defined clinically (100%) and neuroradiographically (39%) with negative CSF cytology were evaluated with CSF biochemical markers. In only four patients (22%), CSF biochemical markers corroborated a diagnosis of carcinomatous meningitis.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9566421     DOI： 10.1212/wnl.50.4.1173

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  10 in total

Review 1.  Leukemia and the nervous system.

Authors:  Marc C Chamberlain
Journal:  Curr Oncol Rep       Date:  2005-01       Impact factor: 5.075

Review 2.  Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials.

Authors:  Marc Chamberlain; Riccardo Soffietti; Jeffrey Raizer; Roberta Rudà; Dieta Brandsma; Willem Boogerd; Sophie Taillibert; Morris D Groves; Emilie Le Rhun; Larry Junck; Martin van den Bent; Patrick Y Wen; Kurt A Jaeckle
Journal:  Neuro Oncol       Date:  2014-05-27       Impact factor: 12.300

Review 3.  Leukemic and lymphomatous meningitis: incidence, prognosis and treatment.

Authors:  Marc C Chamberlain; Craig Nolan; Lauren E Abrey
Journal:  J Neurooncol       Date:  2005-10       Impact factor: 4.130

Review 4.  Leptomeningeal metastases: a RANO proposal for response criteria.

Authors:  Marc Chamberlain; Larry Junck; Dieta Brandsma; Riccardo Soffietti; Roberta Rudà; Jeffrey Raizer; Willem Boogerd; Sophie Taillibert; Morris D Groves; Emilie Le Rhun; Julie Walker; Martin van den Bent; Patrick Y Wen; Kurt A Jaeckle
Journal:  Neuro Oncol       Date:  2017-04-01       Impact factor: 12.300

Review 5.  Neoplastic meningitis.

Authors:  Ana Aparicio; Marc C Chamberlain
Journal:  Curr Neurol Neurosci Rep       Date:  2002-05       Impact factor: 5.081

Review 6.  Neoplastic meningitis.

Authors:  Marc C Chamberlain
Journal:  Curr Neurol Neurosci Rep       Date:  2008-05       Impact factor: 5.081

7.  Leptomeningeal carcinomatosis after major remission to taxane-based front-line therapy in patients with advanced breast cancer.

Authors:  Christos Kosmas; Nikolaos A Malamos; Nicolas B Tsavaris; Melina Stamataki; Stefanos Stefanou; Achilleas Gregoriou; Sofia Rokana; Maria Vartholomeou; Minas J Antonopoulos
Journal:  J Neurooncol       Date:  2002-02       Impact factor: 4.130

8.  Genotyping of cerebrospinal fluid in lung cancer patients with leptomeningeal metastasis.

Authors:  Naifu Nie; Haodong Zhou; Kejun Zhang; Lan Liu; Nuo Luo; Renyuan Wang; Xin Li; Mengxiao Zhu; Chen Hu; Yubo Wang; Zhulin Liu; Li Li; Yong He
Journal:  Thorac Cancer       Date:  2022-07-27       Impact factor: 3.223

9.  Carcinomatous meningitis: Leptomeningeal metastases in solid tumors.

Authors:  Emilie Le Rhun; Sophie Taillibert; Marc C Chamberlain
Journal:  Surg Neurol Int       Date:  2013-05-02

Review 10.  Neoplastic meningitis.

Authors:  L Kim; M J Glantz
Journal:  Curr Treat Options Oncol       Date:  2001-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.